Skip to main content
Download PDF

Quercetin inhibits caspase-1-dependent macrophage pyroptosis in experimental folic acid nephropathy

Chinese Medicine volume 19, Article number: 11 (2024) Cite this article

Abstract

Background

The role of pyroptosis in kidney disease is limited and incomplete. Quercetin, a flavonoid compound present in a variety of fruits, vegetables, and plants, has shown antioxidant and anti-inflammatory properties. This study was designed to validate the importance of pyroptosis in an experimental model of folic acid nephropathy and to explore the effect of quercetin in protecting against pyroptosis.

Methods

Gene set enrichment analysis (GSEA) and weighted gene co-expression network analysis (WGCNA) were used to establish the correlation between pyroptosis and folic acid nephropathy. Immune cell infiltration, network pharmacology and single-cell RNA sequencing analysis were utilized to ascertain the specific target of quercetin in relation to pyroptosis. Finally, quercetin’s role was verified in vivo and in vitro.

Results

The GSEA analysis revealed a significant correlation between pyroptosis and folic acid nephropathy (NES = 1.764, P = 0.004). The hub genes identified through WGCNA were closely associated with inflammation. Molecular docking demonstrated a strong binding affinity between quercetin and caspase-1, a protein known to be involved in macrophage function, as confirmed by immune cell infiltration and single-cell analysis. Quercetin demonstrated a significant amelioration of kidney injury and reduction in macrophage infiltration in the animal model. Furthermore, quercetin exhibited a significant inhibition of caspase-1 expression, subsequently leading to the inhibition of pro-inflammatory cytokines expression, such as IL-1β, IL-18, TNF-α, and IL-6. The inhibitory effect of quercetin on macrophage pyroptosis was also confirmed in RAW264.7 cells.

Conclusion

This study contributes substantial evidence to support the significant role of pyroptosis in the development of folic acid nephropathy, and highlights the ability of quercetin to downregulate caspase-1 in macrophages as a protective mechanism against pyroptosis.

Introduction

Folic acid (FA) is a crucial factor in cellular growth and division, as it plays an essential role in the synthesis of DNA and RNA. Adequate intake of FA before and during early pregnancy significantly reduces the risk of neural tube defects [1]. FA supplementation may be prescribed to prevent various diseases, such as stroke [2], cardiovascular disease [3], and depression [4]. Nevertheless, excessive FA consumption can result in serious complications, including kidney injury [5].

Pyroptosis, a form of programmed cell death, assumes a pivotal role in diverse kidney diseases [6]. Cellular swelling and rupture occur during the pyroptotic process, releasing intracellular contents and eliciting an immune response. Consequently, this cascade engenders cellular demise and inflammation, contributing to kidney injury. Studies have demonstrated that the targeting of inflammasomes and caspase-1 (CASP-1) can mitigate the inflammatory response and cellular death associated with pyroptosis, thereby reducing kidney injury [7, 8]. However, the specific role of pyroptosis in FA-induced renal injury is unclear. It has clinical application prospects to seek drugs to reduce renal injury by reducing cell pyrodeath.

Quercetin, a flavonoid compound found in fruits, vegetables, and plants, demonstrates diverse biological activities encompassing antioxidant [9], anti-inflammatory [10], and anticancer properties [11]. There is accumulating evidence suggesting that quercetin has a potential role against pyroptosis [12,13,14]. The present study further elucidated the potential mechanisms related to pyroptosis of quercetin ameliorating FA-induced kidney damage. Figure 1 displays a flowchart illustrating the methodology of this study.

Fig. 1
figure 1

Flowchart of the study

Full size image

Materials and methods

Data collection and preprocessing

GSE156686 and GSE222570 were downloaded from the Gene Expression Omnibus (GEO) database (http://www.ncbi.nlm.nih.gov/geo/). The two datasets contain the high throughout sequencing data of nine FA-induced kidney lesion samples and seven control samples in total. To eliminate batch effects, the expression profiles were integrated using the Combat function of the "sva" package.

The structural formula of quercetin was obtained from the PubChem database (https://pubchem.ncbi.nlm.nih.gov/). Quercetin targets were selected from the PharmMapper database (http://www.lilab-ecust.cn/pharmmapper/) and the Swiss TargetPrediction database (http://www.swisstargetprediction.ch/). The data downloaded from the PharmMapper database was converted into the corresponding genes using the UniProt database (https://www.uniprot.org/). The potential drug targets predicted by the two databases, excluding duplicates, were chosen for further verification.

The dataset for single cell RNA sequencing of kidney tissue in the FA-induced renal injury model was also acquired from GSE156686. Downstream analysis was performed using the "Seurat" package.The Mouse Cell Atlas and CellMarker were used to annotate cell types manually.

Data analysis

Differential expression analysis was conducted on the normalized datasets using the "limma" package (version 3.54.1). We defined differentially expressed genes (DEGs) based on the thresholds of |log2 fold change (FC)|> 1 and P.adj value < 0.05.

Thirty-three pyroptosis related genes were obtained from published literature [15]. The enrichment strength was indicated using the normalized enrichment score (NES). The level of significance was defined at P < 0.05.

Weighted gene co-expression network analysis (WGCNA) was used to analyze differential genes in the integrated dataset, identifying of coexpression modules and key genes associated with pyroptosis and FA-induced kidney injury. Gene significance (GS) greater than 0.7 and module membership (MM) greater than 0.8 were used to assess the correlation between gene expression and sample trait. Functional enrichment analysis, including Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, was performed on key module genes using Sangerbox tools (http://sangerbox.com/). Furthermore, WGCNA identified key genes were subjected to protein–protein interaction network analysis using the STRING database (https://cn.string-db.org/) and visualized with Cytoscape software.

The CIBERSORT algorithm was used to assess the presence of immune cell infiltration in kidney tissues based on transcriptome data, with a statistical significance threshold of P < 0.05.

The 3D structure of quercetin was obtained from the PubChem database, whereas the protein target was acquired from the Protein Data Bank database. The removal of solvent molecules and ligands was performed using Pymol software, followed by the utilization of AutoDock Tools software to incorporate hydrogen, calculate charges, and assign atomic types. The resulting data was saved in the pdbqt format. Openbel software was used to convert the 3D structure from pdbqt to pdb format. The visualization of specific binding sites and atomic distances between active components and proteins was accomplished using Pymol software.

Folic acid induced renal kidney model and cell culture

Twenty-four C57BL/6J male mice were randomly assigned to four groups (n = 6): the negative control group (group CON), the FA group (group FA), the quercetin group (group Q), and the quercetin treated with FA group (group FA + Q). The mice in group FA were injected with a single dose of FA (F7876, Sigma-Aldrich) (250 mg/kg, dissolved in 300 mM NaHCO3, i.p.), while the group CON received an equivalent volume of vehicle (300 mM NaHCO3, i.p.). Starting from the day after FA injection, the mice in groups Q and FA + Q were administered quercetin (HY-18085, MCE) at a dosage of 50 mg/kg/day (i.p.). Kidney and blood samples were collected on day 7 after the first injection of FA.

RAW264.7 cells were grown in DMEM supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin and maintained at 37 ℃ in a 5% CO2 incubator. Before experimentation, cells were seeded into 6-well plates and incubated overnight. Subsequently, the cells were treated with FA (400 gμ/mL) or a combination of FA (400 gμ/mL) and quercetin (10 mM) for 24 h.

Cell viability and renal function evaluation

RAW264.7 cells were cultured in 96-well plate and subsequently exposed to varying concentrations of FA (25, 50, 100, 200, 400 and 800 μg/mL) or quercetin (1, 5, 10, 20, 40 and 80 mM). After 2 h of incubation with CCK-8 solution, the optical density at 450 nm was determined to assess cell viability. The obtained results were percentages relative to control and were presented as mean ± standard deviation based on three independent experiments.

According to the instructions provided by the manufacturer, serum creatinine and blood urea nitrogen (BUN) were measured to evaluate renal function.

Western blots

Using a lysing buffer, we extracted protein from treated RAW264.7 cells or mouse tissue. Protein concentration was determined using the BCA assay. Protein expression levels were assessed through standard western blot procedures, using anti-rabbit primary antibodies targeting NLRP3 (ABclonal, A21906), CASP-1 (ABclonal, A0964), CASP-1(p10) (Abcam, ab179515), IL-18 (ImmunoWay, YN1926), GSDMD (Abcam, ab219800), IL-6 (ABclonal, A0286), TNF-α (ABclonal, A0277), and IL-1β (ABclonal, A16288). A secondary antibody, Goat Anti-Rabbit IgG(H + L)-HRP Conjugate (SAB, L35009), was used. The images were visualized using the Tanon-5200 Chemiluminescent Imaging System, and densitometric analysis was conducted using ImageJ.

Kidney histology

The kidneys were fixed using a 4% paraformaldehyde solution for a duration of 24 h before paraffin embedding. Sections of the embedded samples were stained with hematoxylin and eosin (H&E) at a thickness of 4 μm. The semiquantitative calculation of the tubular injury score was performed as follows (score 0: no tubular injury; score 1: < 10% tubular injury; score 2: 10–24% tubular injury; score 3: 25–49% tubular injury; score 4: 50–74% tubular damage; score 5: damaged tubules ≥ 75%). Every specimen was subjected to random examination using 400× magnification in ten distinct fields. Six samples were analyzed from each experimental group.

Immunofluorescence

For immunofluorescence analysis, the renal tissues were embedded in an optimum cutting temperature compound and prepared as frozen sections with a thickness of 5 μm. These sections/cell climbing pieces were fixed with acetone for 10 min and washed with PBS. The sections/pieces were treated with 5% goat serum for 1 h to prevent nonspecific binding. The tissues/macrophages were incubated overnight at 4 ℃ with anti-CASP-1 antibody and anti-F4/80 antibody (Invitrogen, 14-4801-82). The immunofluorescence signals were detected using secondary antibodies, specifically Alexa Fluor 594 donkey anti-rabbit (Abcam, ab150076) and FITC goat anti-rat (Servicebio, GB22302). Additionally, the slides were counterstained with DAPI to visualize the nucleus and subsequently observed under a fluorescent microscope.

Immunohistochemistry

The paraffin-embedded sections were used for immunohistochemistry staining. Following antigen retrieval, the sections were quenched using a 3% H2O2 block for 15 min. Incubation with antibodies targeting CASP-1 and F4/80 was performed overnight at 4 °C. Following three washes with PBS, the sections were incubated for 1 h with secondary antibodies that were HRP-labeled. Diaminobenzidine solution was then applied to the slides. The resulting chromogenic reaction, which causes the epitope sites to turn brown, was observed under a microscope. Hematoxylin staining was conducted to counterstain the nuclei.

Statistical analysis

The data were analyzed using the GraphPad Prism software and presented as mean ± SD/SEM with individual data points as applicable. One-way analysis of variance (ANOVA) with a significance level of P < 0.05 was used to assess differences between multiple groups.

Results

Screening of differentially expressed genes

Based on a significance level of P.adj < 0.05 and a threshold of |logFC|> 1, 3068 DEGs were identified, with 1629 upregulated and 1439 downregulated. The volcano plots in Fig. 2A visually represent these DEGs. As displayed in Fig. 2B, heat map exhibited the 20 most significant DEGs among the upregulated and downregulated genes.

Fig. 2
figure 2

Identification of differentially expressed genes (DEGs) in folic acid nephropathy model. A Volcano map of DEGs (|logFC|> 1, P.adj < 0.05); B Heatmap shows the most significant 20 genes in up- and down-regulation

Full size image

GSEA of pyroptosis and WGCNA of the combined dataset

The FA-induced renal injury was markedly correlated with pyroptosis (NES = 1.764, P = 0.004) (Fig. 3A). To build a scale-free network, a soft-threshold of 9 was chosen according to the scale-free topology criterion with an R2 value of 0.9 (Fig. 3B). After transforming the adjacency matrix into a TOM matrix, the weighted correlation was used to assess the similarity between nodes. Seven modules were obtained based on average hierarchical clustering and dynamic tree clipping techniques in Fig. 3C and D.

Fig. 3
figure 3

The relationship between pyroptosis and folic acid nephropathy analysed by GSEA and WGCNA. A GSEA analysis for pyroptosis in combined dataset; B network topology analysis under various soft threshold power; C the clustering tree and co-expression network of co-representation network modules are constructed based on 1-TOM matrix; D the relationship of three traits and seven modules; E the scatterplot describing the relationship between MM and GS in turquoise module related to pyroptosis; F the scatterplot describing the relationship between MM and GS in turquoise module related to FA

Full size image

Among these modules, the turquoise module exhibited a strong association with pyroptosis (cor = 0.64, P = 0.008) and FA exposure (cor = 0.96, P = 2E−09). Consequently, the turquoise module, which is linked to both FA and pyroptosis, was chosen as the hub module for subsequent analysis. The scatter plots illustrating the distribution of genes within the hub module are shown in Fig. 3E and F.

The genes exhibiting |GS|> 0.7 and |MM|> 0.8 within each module were subsequently compared to the DEG list, and genes displaying similarity were chosen as the ultimate hub-genes (Fig. 4A). The protein–protein interaction network of the hub genes was assessed using the STRING database and visualized through Cytoscape (Fig. 4B). The outcomes of the KEGG enrichment analysis showed that the genes were primarily found in the TNF signaling pathway, C-type lectin receptor signaling pathway, and IL-17 signaling pathway (Fig. 4C). The GO enrichment analysis revealed that the genes under investigation were significantly associated with chemokine-mediated signaling pathway, leukocyte migration, IL-6 production, and leukocyte mediated immunity (Fig. 4D). These processes are highly interconnected and closely linked to the phenomenon of inflammation.

Fig. 4
figure 4

Analysis of hub genes in dataset through WGCNA. A Venn diagram showed the intersection genes between module genes and DEGs; B PPI network of hub genes; C KEGG enrichment of hub genes; D GO enrichment of hub genes

Full size image

Immune cell infiltration results

The heatmap displayed the disparity in immune cell infiltration between two groups (Fig. 5A). The violin plot demonstrated that, in comparison to the control sample, NK cells resting, macrophages M1, dendritic cells resting, and activated mast cells exhibited higher levels of infiltration (Fig. 5B). Furthermore, an analysis of correlation was conducted to examine the connection between infiltrated immune cells, revealing several pairs of positively and negatively correlated immune cells (Fig. 5C).

Fig. 5
figure 5

Immune infiltration landscape in folic acid nephropathy. A Heat map of relative proportions of 22 infiltrated immune cells; B comparisons of immune cells between folic acid induced kidney injury and control; C the co-expression patterns among fractions of immune cells

Full size image

The target of quercetin alleviated kidney injury related to pyroptosis

360 target genes of quercetin (Additional file 1: Table S1) were gained. By identifying the hub genes within the module and their intersection with pyroptosis-related genes, it was determined that CASP-1 may serve as a potential target for quercetin in mitigating pyroptosis-induced kidney injury (Fig. 6A).

Fig. 6
figure 6

Identify the target of quercetin related to pyroptosis. A Venn diagram showed the target of quercetin related to pyroptosis in FA animal model; B the relationship between CASP-1 expression and immune cell infiltration level; C cell subset annotation of renal tissue; D expression pattern of CASP-1 at the single cell level; E molecular docking of CASP-1 and quercetin

Full size image

To examine the relationship between the CASP-1 gene and immune cells, we analyzed the expression data of CASP-1 in the combined dataset. A positive correlation was found between the expression value of CASP-1 and the levels of infiltration of macrophages M1, dendritic cells resting, NK cells resting, and mast cells activated. The strongest correlation was observed with macrophages M1 (R = 0.82) (Fig. 6B). To perform unsupervised cell clustering analysis, we used t-distributed random neighborhood embedding (t-SNE). Figure 6C demonstrates the segregation of renal tissue into seven distinct clusters. Subsequently, the expression pattern of CASP-1 in the aforementioned cell clusters was examined, and its expression at the single-cell level was confirmed (Fig. 6D). Notably, the macrophages exhibited a significantly elevated expression of CASP-1. The binding energy of − 6.49 kcal/mol suggests a favorable binding affinity between quercetin and CASP-1 (Fig. 6E).

Quercetin alleviated kidney injury of folic acid animal model

Quercetin did not exhibit any discernible effect on normal mice. However, it demonstrated a protective function by diminishing the concentrations of BUN and serum creatinine (Fig. 7A). The evaluation of tubular injury in kidney sections through H&E staining revealed that quercetin significantly mitigated histologic injury (Fig. 7B). Western blot analysis of the kidney exhibited elevated expression levels of NLRP3, CASP-1, CASP-1(p10), N-GSDMD, IL-18, IL-1β, IL-6, and TNF-α in group FA, which were subsequently normalized by the administration of quercetin (Fig. 7D). There was a higher CASP-1 and F4/80 positive area in group FA compared to groups CON and Q. While the effect was attenuated by the administration of quercetin (Fig. 8A, C). To further investigate the type of macrophage death in the kidneys and the potential mechanism of quercetin’s protective effect against renal injury, CASP-1 and F4/80 double staining was performed to indicate the co-localization of CASP-1 in macrophages (Fig. 8E). These findings suggested that macrophage pyroptosis is a characteristic of FA-induced renal injury and that quercetin can suppress macrophage pyroptosis.

Fig. 7
figure 7

Quercetin alleviates kidney injury and inhibits pyroptosis in folic acid nephropathy model. A Serum level of BUN and creatinine; B H&E staining showed quercetin inhibited kidney injury induced by FA; C the renal tubular injury score of different groups, data represent mean ± SEM (n = 6); D Western blot revealed quercetin attenuated protein expression related pyroptosis in FA animal model; E quantitative analysis of western blot, data represent mean ± SD (n = 6). Scale bar = 50 μm, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001

Full size image
Fig. 8
figure 8

Quercetin inhibits macrophage infiltration and CASP-1 expression in vivo. A Representative Immunohistochemical images of F4/80+ cells in kidney sections; B quantitative analysis of F4/80+ positive cells in the kidneys; C representative Immunohistochemical images of CASP-1 in kidney sections; D quantitative analysis of CASP-1 positive area in the kidneys; E representative photomicrographs showing the immunofluorescence staining for F4/80+ (green) and CASP-1 (red) among different groups; F quantitative analysis of F4/80+ positive cells and CASP-1 positive area in kidney sections measured by immunofluorescence staining. Data represent mean ± SD (n = 6). Scale bar = 50 μm, ****p < 0.0001

Full size image

Quercetin inhibited RAW264.7 pyroptosis

At concentrations of quercetin 10 μM /FA 200 gµ/mL or lower, there was no observed effect on the RAW 264.7 cell viability (Fig. 9A, B). Exposure to FA increased in the expression levels of pyroptosis-related proteins NLRP3, CASP-1, CASP-1(p10) and GSDMD, subsequently promoting the production of pro-inflammatory mediators such as Il-1β, IL-18, IL-6, and TNF-α (Fig. 9C). However, quercetin significantly inhibited the expression of these proteins and the production of pro-inflammatory mediators. To further assess the effect of FA on macrophages, the expression of CASP-1 was measured by co-staining with the macrophage marker F4/80. The results demonstrated a significant increase in intracellular CASP-1 fluorescence intensity upon exposure to FA, which was significantly suppressed by treatment with quercetin (Fig. 9E).

Fig. 9
figure 9

Quercetin inhibits CASP-1 expression and related pyroptosis in RAW264.7 cells. A Cytotoxic assessment of quercetin in RAW264.7 cells; B cytotoxic assessment of folic acid in RAW264.7 cells; C, D immunoblots and quantitative histograms showing the results of Western blot analysis for the expression of protein related to pyroptosis; E representative microscopy images of cells stained for F4/80+ (green), CASP-1 (red) and nuclei (blue) to detect expression of CASP-1 (Scale bars: 50 μm); F quantitative analysis of CASP-1 positive area in cells. Data represent mean ± SD (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001

Full size image

Discussion

Pyroptosis has been documented in diverse inflammatory kidney disorders involving acute kidney injury [16], chronic kidney disease [7], and diabetic nephropathy [17]. The mechanisms underlying pyroptosis in tubular epithelial cells involve Caspase-11/GSDMD [18], Caspase-3/GSDME [19], and miR-342-3p/CASP-1 [20]. Caspase-11/4 and GSDMD have been found to contribute to podocyte pyroptosis in diabetic nephropathy [21]. Vascular smooth muscle cell pyroptosis was also identified in adenine-induced CKD mice [7]. These findings highlight the relevance of pyroptosis in kidney disease. Our study used GSEA and WGCNA analysis to unveil further the substantial involvement of pyroptosis in the advancement of kidney injury. As a highly pro-inflammatory form of cell death, pyroptosis exhibits a close association with immune cell infiltration [22], which is recognized as a crucial mechanism contributing to kidney injury. As shown in our study, the enrichment analysis of the identified hub genes demonstrated their predominant participation in inflammatory pathways and processes.

CASP-1, an inflammatory caspase, is critical in the canonical inflammasome-mediated pyroptosis and cytokine maturation. Upon activation, CASP-1 cleaves GSDMD, an effector molecule involved in pyroptosis. The cleaved form of GSDMD then induces the formation of pores in the cell membrane, causing cellular swelling and rupture, ultimately releasing pro-inflammatory cytokines and cell debris. Several studies have suggested a potential association between CASP-1 activation and conditions such as ischemia–reperfusion injury [23], diabetic nephropathy [24], and the progression of renal fibrosis [7]. VX-765, a specific inhibitor targeting CASP-1, demonstrated a mitigating effect on pyroptosis in both ketamine-induced renal injury [25] and diabetes [26]. Despite the validation of various CASP-1 inhibitors in animal models of kidney disease [27, 28], their utilization in humans is constrained due to their unfavorable toxicity profiles.

Quercetin, a dietary compound, has been found to possess potential protective properties against kidney disease [29, 30]. Its ability to suppress inflammasome activation [31] and regulate pro-inflammatory cytokines [32] suggests that it may have the potential to mitigate pyroptotic cell death. Quercetin mitigated the neurotoxicity induced by multi-walled carbon nanotubes by inhibiting pyroptosis in neuron cells [33]. Additionally, quercetin has demonstrated protective effects against intestinal inflammation [34], osteolysis [35], steatohepatitis [36] and LPS-induced lung injury [37] by inhibiting pyroptosis. Moreover, quercetin ameliorated HK-2 cell pyroptosis in lupus nephritis [38]. Through molecular docking and single-cell analysis, the target of quercetin was identified as CASP-1, which is mainly expressed in macrophages. The present study revealed a significant reduction in CASP-1 levels in macrophages following treatment with quercetin. However, the NLRP3 inflammasome, which serves as the primary mediator for CASP-1 activation, was also mitigated by quercetin. This observation implies that additional mechanisms may be involved in the regulation of quercetin. Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis has been demonstrated in the protection of quercetin anti-atherosclerosis [12]. There is evidence showed that quercetin inhibited THP-1 macrophage pyroptosis induced by LPS/ATP treatment via the TLR2/Myd88/NF-κB and ROS/AMPK pathways [39]. Further investigations are warranted to comprehensively understand the mechanisms and efficacy of quercetin in preventing or ameliorating pyroptosis-related disorders.

Conclusions

The present study proves that pyroptosis plays a significant role in the advancement of kidney injury induced by high doses of folic acid (Fig. 10). Quercetin efficiently reduced the expression of CASP-1 within macrophages, thereby alleviating pyroptosis.

Fig. 10
figure 10

Hypothesis mechanism map was drawn by Figdraw

Full size image

Availability of data and materials

All the data used to support the findings of this study are available from the corresponding author upon reasonable request.

Abbreviations

GSEA:

Gene set enrichment analysis

WGCNA:

Weighted gene co-expression network analysis

FA:

Folic acid

CASP-1:

Caspase-1

GEO:

Gene Expression Omnibus

NES:

Normalized enrichment score

DEG:

Differentially expressed gene

GO:

Gene Ontology

KEGG:

Kyoto Encyclopedia of Genes and Genomes

NLRP3:

NACHT, LRR and PYD domains-containing protein 3

GSDMD:

Gasdermin-D

N-GSDMD:

N terminal of GSDMD

IL:

Interleukin

TNF:

Tumor necrosis factor

References

  1. Dwyer ER, Filion KB, Macfarlane AJ, et al. Who should consume high-dose folic acid supplements before and during early pregnancy for the prevention of neural tube defects? BMJ. 2022;377: e067728.

    Article  PubMed  Google Scholar 

  2. Wang X, Qin X, Demirtas H, et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet. 2007;369(9576):1876–82.

    Article  CAS  PubMed  Google Scholar 

  3. Shirodaria C, Antoniades C, Lee J, et al. Global improvement of vascular function and redox state with low-dose folic acid: implications for folate therapy in patients with coronary artery disease. Circulation. 2007;115(17):2262–70.

    Article  CAS  PubMed  Google Scholar 

  4. Almeida OP, Ford AH, Hirani V, et al. B vitamins to enhance treatment response to antidepressants in middle-aged and older adults: results from the B-VITAGE randomised, double-blind, placebo-controlled trial. Br J Psychiatry. 2014;205(6):450–7.

    Article  PubMed  Google Scholar 

  5. Metz-Kurschel U, Kurschel E, Wagner K, et al. Folate nephropathy occurring during cytotoxic chemotherapy with high-dose folinic acid and 5-fluorouracil. Ren Fail. 1990;12(2):93–7.

    Article  CAS  PubMed  Google Scholar 

  6. Elias EE, Lyons B, Muruve DA. Gasdermins and pyroptosis in the kidney. Nat Rev Nephrol. 2023;19(5):337–50.

    Article  PubMed  Google Scholar 

  7. Pang Q, Wang P, Pan Y, et al. Irisin protects against vascular calcification by activating autophagy and inhibiting NLRP3-mediated vascular smooth muscle cell pyroptosis in chronic kidney disease. Cell Death Dis. 2022;13(3):283.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Cao H, Liang J, Liu J, et al. Novel effects of combination therapy through inhibition of caspase-1/Gasdermin D induced-pyroptosis in lupus nephritis. Front Immunol. 2021;12: 720877.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Oh WY, Ambigaipalan P, Shahidi F. Quercetin and its ester derivatives inhibit oxidation of food, LDL and DNA. Food Chem. 2021;364: 130394.

    Article  CAS  PubMed  Google Scholar 

  10. Fan H, Tang HB, Shan LQ, et al. Quercetin prevents necroptosis of oligodendrocytes by inhibiting macrophages/microglia polarization to M1 phenotype after spinal cord injury in rats. J Neuroinflamm. 2019;16(1):206.

    Article  Google Scholar 

  11. Tang SM, Deng XT, Zhou J, et al. Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects. Biomed Pharmacother. 2020;121: 109604.

    Article  CAS  PubMed  Google Scholar 

  12. Luo X, Weng X, Bao X, et al. A novel anti-atherosclerotic mechanism of quercetin: competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis. Redox Biol. 2022;57: 102511.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Fawzy MA, Nasr G, Ali FEM, et al. Quercetin potentiates the hepatoprotective effect of sildenafil and/or pentoxifylline against intrahepatic cholestasis: role of Nrf2/ARE, TLR4/NF-kappaB, and NLRP3/IL-1beta signaling pathways. Life Sci. 2023;314: 121343.

    Article  CAS  PubMed  Google Scholar 

  14. Zhu Q, Yang L, Yang H, et al. Quercetin alleviates the progression of breast cancer-related depression via inhibiting the pyroptosis and promoting the immune response. Mediat Inflamm. 2022;2022:8011988.

    Article  Google Scholar 

  15. Luo J, Lai J. Pyroptosis-related molecular classification and immune microenvironment infiltration in breast cancer: a novel therapeutic target. J Cell Mol Med. 2022;26(8):2259–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Xiong J, Ran L, Zhu Y, et al. DUSP2-mediated inhibition of tubular epithelial cell pyroptosis confers nephroprotection in acute kidney injury. Theranostics. 2022;12(11):5069–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Lan J, Xu B, Shi X, et al. WTAP-mediated N(6)-methyladenosine modification of NLRP3 mRNA in kidney injury of diabetic nephropathy. Cell Mol Biol Lett. 2022;27(1):51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Miao N, Yin F, Xie H, et al. The cleavage of gasdermin D by caspase-11 promotes tubular epithelial cell pyroptosis and urinary IL-18 excretion in acute kidney injury. Kidney Int. 2019;96(5):1105–20.

    Article  CAS  PubMed  Google Scholar 

  19. Xia W, Li Y, Wu M, et al. Gasdermin E deficiency attenuates acute kidney injury by inhibiting pyroptosis and inflammation. Cell Death Dis. 2021;12(2):139.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Zheng S, Zhang K, Zhang Y, et al. Human umbilical cord mesenchymal stem cells inhibit pyroptosis of renal tubular epithelial cells through miR-342-3p/Caspase1 signaling pathway in diabetic nephropathy. Stem Cells Int. 2023;2023:5584894.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Cheng Q, Pan J, Zhou ZL, et al. Caspase-11/4 and gasdermin D-mediated pyroptosis contributes to podocyte injury in mouse diabetic nephropathy. Acta Pharmacol Sin. 2021;42(6):954–63.

    Article  CAS  PubMed  Google Scholar 

  22. Lou X, Li K, Qian B, et al. Pyroptosis correlates with tumor immunity and prognosis. Commun Biol. 2022;5(1):917.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Jain S, Plenter R, Jeremy R, et al. The impact of Caspase-1 deletion on apoptosis and acute kidney injury in a murine transplant model. Cell Signal. 2021;85: 110039.

    Article  CAS  PubMed  Google Scholar 

  24. Shahzad K, Bock F, Al-Dabet MM, et al. Caspase-1, but not caspase-3, promotes diabetic nephropathy. J Am Soc Nephrol. 2016;27(8):2270–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Bai H, Zhang Z, Ma X, et al. Inhibition of the NLRP3/caspase-1 signaling cascades ameliorates ketamine-induced renal injury and pyroptosis in neonatal rats. Biomed Pharmacother. 2022;152: 113229.

    Article  CAS  PubMed  Google Scholar 

  26. Wen S, Deng F, Li L, et al. VX-765 ameliorates renal injury and fibrosis in diabetes by regulating caspase-1-mediated pyroptosis and inflammation. J Diabetes Investig. 2022;13(1):22–33.

    Article  CAS  PubMed  Google Scholar 

  27. Gu J, Huang W, Zhang W, et al. Sodium butyrate alleviates high-glucose-induced renal glomerular endothelial cells damage via inhibiting pyroptosis. Int Immunopharmacol. 2019;75: 105832.

    Article  CAS  PubMed  Google Scholar 

  28. Tao Y, Kim J, Stanley M, et al. Pathways of caspase-mediated apoptosis in autosomal-dominant polycystic kidney disease (ADPKD). Kidney Int. 2005;67(3):909–19.

    Article  CAS  PubMed  Google Scholar 

  29. Kitamura M, Ishikawa Y. Oxidant-induced apoptosis of glomerular cells: intracellular signaling and its intervention by bioflavinoid. Kidney Int. 1999;56(4):1223–9.

    Article  CAS  PubMed  Google Scholar 

  30. Li Z, Deng H, Guo X, et al. Effective dose/duration of natural flavonoid quercetin for treatment of diabetic nephropathy: a systematic review and meta-analysis of rodent data. Phytomedicine. 2022;105: 154348.

    Article  CAS  PubMed  Google Scholar 

  31. Han X, Xu T, Fang Q, et al. Quercetin hinders microglial activation to alleviate neurotoxicity via the interplay between NLRP3 inflammasome and mitophagy. Redox Biol. 2021;44: 102010.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Liu J, Li X, Yue Y, et al. The inhibitory effect of quercetin on IL-6 production by LPS-stimulated neutrophils. Cell Mol Immunol. 2005;2(6):455–60.

    CAS  PubMed  Google Scholar 

  33. Sallam AA, El-Magd MA, Ahmed MM, et al. Quercetin alleviated multi-walled carbon nanotubes-induced neurotoxicity in mice through inhibition of oxidation, inflammation, and pyroptosis. Biomed Pharmacother. 2022;151: 113160.

    Article  CAS  PubMed  Google Scholar 

  34. Xiao K, Zhou M, Lv Q, et al. Protocatechuic acid and quercetin attenuate ETEC-caused IPEC-1 cell inflammation and injury associated with inhibition of necroptosis and pyroptosis signaling pathways. J Anim Sci Biotechnol. 2023;14(1):5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Cheng Y, Zhao Z, Zhang S, et al. Quercetin alleviates nanoparticle-induced osteolysis via deactivating pyroptosis. Biomater Sci. 2023;11(13):4616–29.

    Article  CAS  PubMed  Google Scholar 

  36. Zhan ZY, Wu M, Shang Y, et al. Taxifolin ameliorate high-fat-diet feeding plus acute ethanol binge-induced steatohepatitis through inhibiting inflammatory caspase-1-dependent pyroptosis. Food Funct. 2021;12(1):362–72.

    Article  CAS  PubMed  Google Scholar 

  37. Chen LL, Song C, Zhang Y, et al. Quercetin protects against LPS-induced lung injury in mice via SIRT1-mediated suppression of PKM2 nuclear accumulation. Eur J Pharmacol. 2022;936: 175352.

    Article  CAS  PubMed  Google Scholar 

  38. Chen HY, Chiang YF, Hong YH, et al. Quercetin ameliorates renal injury and pyroptosis in lupus nephritis through inhibiting IL-33/ST2 pathway in vitro and in vivo. Antioxidants. 2022;11(11):2238.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Luo X, Bao X, Weng X, et al. The protective effect of quercetin on macrophage pyroptosis via TLR2/Myd88/NF-κB and ROS/AMPK pathway. Life Sci. 2022;291: 120064.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This work was supported by National Natural Science Foundation of China (82060130); Natural Science Foundation of Guangdong Province (2021A1515012453) and President Foundation of The Third Affiliated Hospital of Southern Medical University (YQ202213).

Author information

Author notes

  1. Xianli Gao and Caiyun Guo are co-first authors.

Authors and Affiliations

  1. Department of Anesthesiology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China

    Xianli Gao, Caiyun Guo, Wenjun Li, Yingdong Deng, Wenjun Ning, Jiaqi Xie, Xiaoying Zhan & Jun Zhou

  2. Department of Anesthesiology, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, China

    Xianli Gao & Zengping Huang

  3. Department of Anesthesiology, The First People’s Hospital of Kashgar, Xinjiang, China

    Youling Fan

  4. Department of Anesthesiology, The Second People’s Hospital of Panyu, Guangzhou, China

    Youling Fan

  5. Department of Anesthesiology, Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, China

    Hongtao Chen

Authors
  1. Xianli Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Caiyun Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wenjun Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yingdong Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wenjun Ning
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jiaqi Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xiaoying Zhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Youling Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hongtao Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Zengping Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Jun Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

XG and CG: methodology, investigation, data curation, Formal analysis and writing—original draft. WL, WN, JX and XZ: resources and data curation. YD: software. YF and HC: funding acquisition. ZH and JZ: conceptualization, supervision and writing—review and editing. All authors contributed to the article and confirmed the final manuscript.

Corresponding author

Correspondence to Jun Zhou.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Animal Ethics Committee of the Third Affiliated Hospital of Southern Medical University.

Consent for publication

Not applicable.

Competing interests

The authors declare no conflict of interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Target genes of quercetin.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gao, X., Guo, C., Li, W. et al. Quercetin inhibits caspase-1-dependent macrophage pyroptosis in experimental folic acid nephropathy. Chin Med 19, 11 (2024). https://doi.org/10.1186/s13020-024-00885-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13020-024-00885-2

Keywords

Chinese Medicine

ISSN: 1749-8546

Contact us